Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● Its low valuation, with P/E ratio at 7.62 and 7.24 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.57 for the 2022 fiscal year.

● The company's share price in relation to its net book value makes it look relatively cheap.

● This company will be of major interest to investors in search of a high dividend stock.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.


Weaknesses

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The company is highly valued given the cash flows generated by its activity.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.